Investor Alert: Kaplan Fox Announces Investigation Of SteadyMed Ltd.

NEW YORK, Sept. 1, 2017 /PRNewswire/ -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of SteadyMed Ltd. ("SteadyMed" or the "Company") (NASDAQ: STDY).On April 5, 2017, SteadyMed, a specialty pharmaceutical company, announced the...